laboratory notes
Back-exchange of deuterium in neutron crystallography: characterization by IR spectroscopy
aLife Sciences Group, Institut Laue–Langevin, 71 avenue des Martyrs, Grenoble 38042, France, bFaculty of Natural Sciences, Keele University, Keele ST5 5BG, UK, cLarge-Scale Structures Group, Institut Laue–Langevin, 71 avenue des Martyrs, Grenoble 38042, France, and dEuropean Synchrotron Research Facility, 71 avenue des Martyrs, Grenoble 38043, France
*Correspondence e-mail: tforsyth@ill.fr
The application of IR spectroscopy to the characterization and quality control of samples used in neutron crystallography is described. While neutron crystallography is a growing field, the limited availability of neutron beamtime means that there may be a delay between crystallogenesis and data collection. Since essentially all neutron crystallographic work is carried out using D2O-based solvent buffers, a particular concern for these experiments is the possibility of H2O back-exchange across reservoir or capillary sealants. This may limit the quality of neutron scattering length density maps and of the associated analysis. Given the expense of central facility beamtime and the effort that goes into the production of suitably sized (usually perdeuterated) crystals, a systematic method of exploiting IR spectroscopy for the analysis of back-exchange phenomena in the reservoirs used for crystal growth is valuable. Examples are given in which the characterization of D2O/H2O back-exchange in transthyretin crystals is described.
1. Introduction
The use of neutron crystallography to study biological macromolecules has been expanding in recent years (Blakeley et al., 2015). The technique is of particular importance for the study of protonation states, protein–water interactions and protein–ligand interactions. It allows the details of intricate hydrogen-bonding networks to be probed, as well as the observation of more exotic ionic species (e.g. H3O+). Specific examples include the study of enzyme mechanisms (Casadei et al., 2014; Oksanen et al., 2014; Kwon et al., 2016), protein–drug interactions (Weber et al., 2013; Gerlits et al., 2016) and redox systems (Cuypers et al., 2013). The advantage of using neutrons is that the coherent scattering lengths for protium (1H) and deuterium (2H) are of a similar magnitude to those of other common elements of a macromolecule (e.g. C, N, O and S). This means that, in contrast with the situation for X-ray diffraction, they have clear visibility in neutron crystallographic studies. However, there are several factors to be considered when studying biological macromolecules with neutrons. The neutron coherent scattering length of protium carries a negative sign, which can cause cancellation effects in neutron scattering length density maps (hereafter referred to as neutron maps) (Fisher et al., 2014). Another important point is that protium, which accounts for about half of the atoms in biological macromolecules, has a very large incoherent scattering (80.27 barn; 1 barn = 100 fm2), arising from the two spin states of the atom. This severely impairs the accuracy with which the coherent crystallographic data can be measured. This problem can be largely avoided by replacing protium with its isotope, deuterium, which has a much lower (2.05 barn) and a positive coherent scattering length.
Neutron macromolecular crystallography therefore benefits from the use of deuteration – ideally perdeuteration, where all protein and solvent protium atoms are replaced by deuterium. Perdeuterated protein is typically produced in vivo and purified using protiated reagents and solvents (Haertlein et al., 2016). In the final stages of purification and crystallization, the H2O solvent is usually replaced by D2O. In addition to replacing the solvent (∼40–50% of the crystal volume), this, in principle, also results in the replacement of solvent-accessible labile protium atoms (∼20–25%) on the protein backbone and side-chains (i.e. N—H, S—H and O—H groups). The routine use of perdeuterated crystals has been one of the major developments for neutron macromolecular crystallography in recent years (Blakeley et al., 2008; Gardberg et al., 2010; Tomanicek et al., 2011; Howard et al., 2011, 2016; Munshi et al., 2012; Cuypers et al., 2013; Haupt et al., 2014; Laulumaa et al., 2015). It reduces the crystal volume needed for data collection by at least an order of magnitude compared with D2O-soaked/grown protiated crystals. However, despite recent developments (Blakeley et al., 2015), the crystal volumes typically required are still ∼0.10 mm3, several orders of magnitude larger than those normally used for X-ray crystallography. Given the high demand for neutron beamtime, and the time and effort required for crystallogenesis and data collection, it is of crucial importance to ensure that the samples produced are of the best quality and have the highest possible exchange of protium by deuterium. There is currently no method that is used systematically to assess the D2O/H2O content of crystals prior to data collection. This is a major difficulty, given that back-exchange of D2O by H2O can occur at various stages during crystallogenesis and/or sample mounting (Bouquiere et al., 1993, 1994), and this may impact on data quality and complicate subsequent interpretation.
Here we describe a method using Fourier transform IR (FT–IR) spectroscopy to monitor the composition of protein solvent prior to and after crystallization, and after sample mounting. Fig. 1 shows the absorption spectra of pure liquid H2O and liquid D2O at room temperature. H2O has a characteristic resonance frequency at ∼3265 cm−1 because of the existence of the O—H whereas D2O resonates at a lower frequency of ∼2468 cm−1 owing to the stronger O—D bond (Scheiner & Čuma, 1996). Since the main interest here is to monitor the ratio of H2O/D2O in the sample, we focus on the ratio of these two peaks and its significance for exchange in solvent and protein side-chain groups. This of course also has implications for the exchange of labile protium atoms on the backbone amide groups. For example, at the data collection stage it is possible to record FT–IR data from the mother liquor held in the sample capillary. A fundamental (but reasonable) assumption is that a spectrum recorded in this way will reflect both the solvent content in the crystal and the deuterium exchange in the protein.
2. Methods
2.1. Sample preparation and crystallization
The protein samples used were deuterated recombinant transthyretin (TTR) protein. The details of the expression and purification have been described previously (Haupt et al., 2011; Yee et al., 2016). While the deuterated TTR was expressed under conditions where only deuterium atoms were present, protiated solutions were used during purification and it was assumed that the labile deuterium atoms in the protein were exchanged by protium. Prior to protein crystallization, the purified protein was buffer-exchanged using a deuterated solution so that the labile protium atoms would be replaced by deuterium. Deuterated TTR crystals were then grown at 291 K using sitting-drop vapour diffusion in deuterated malonate buffer [sodium malonate was dissolved in D2O, and the pD was adjusted using malonic acid which had been dehydrated (by heat and vacuum) and redissolved in D2O (repeated three times)]. Crystal A was crystallized in 2.1 M malonate pD 6.4 in a 1:1 protein-to-buffer ratio and a protein concentration of 20 mg ml−1, whereas crystal B was crystallized in 1.9 M malonate pD 6.4 with a 7:5 protein-to-buffer ratio and a protein concentration of 25 mg ml−1. Both crystals were grown to ∼0.5 mm3 using the same TTR protein variant and were of P21212 with unit-cell dimensions of a = 43.8 Å, b = 86.3 Å and c = 65.5 Å. For neutron data collection, the crystals were mounted in quartz capillaries and surrounded by a small amount of mother liquor from the crystallization well. The capillary was sealed tightly using wax to eliminate the diffusion of gas and atmospheric water.
2.2. X-ray and neutron data collection and processing
Details of the neutron and X-ray data collection approaches that have been used previously for TTR have been reported by Haupt et al. (2014). Neutron quasi-Laue diffraction data were collected at room temperature using the LADI-III instrument at the ILL (Blakeley et al., 2010). Data were processed to a maximum resolution of 1.8 Å. X-ray diffraction data were recorded on the beamlines MASSIF-1 (Bowler et al., 2015) and ID30B at the ESRF (Mueller-Dieckmann et al., 2015) for crystals A and B, respectively. Data were recorded at room temperature on the same capillary-mounted crystals as used for data collection on LADI-III. Data were processed to the same maximum resolution of the corresponding neutron data, i.e. 1.8 Å. PDB code 5clx was used as the starting model for joint X-ray and neutron The neutron Rwork and Rfree values for the final model of crystal A were 0.202 and 0.238, respectively, while the X-ray Rwork and Rfree values were 0.173 and 0.205, respectively. For crystal B, the Rwork and Rfree values were 0.211 and 0.260 for neutrons, and 0.172 and 0.210 for X-rays, respectively.
2.3. FT–IR spectroscopy measurement
The FT–IR spectrometer used was an FT/IR-4600 (JASCO). It is equipped with an ATR Pro One sample cell, a single-reflection ATR with a monolithic diamond crystal, which can be used for the analysis of aqueous or solid samples. For the measurement of a solid sample, a compression clamp is used to ensure that the sample is in contact with the ATR crystal. A background spectrum was first obtained from an empty sample cell. 1.5 µl of liquid sample was then pipetted into to the sample cell for measurement. Liquid samples can be pipetted from the mother liquor surrounding the crystal in the capillary or directly from the crystallization plate, or from any buffer solution used during purification and crystallization of protein. The current design of the machine does not allow measurements to be performed directly on the sample in the capillary because of the compression clamp. Sample spectra (16 scans) were recorded over a wavenumber range of 4000–400 cm−1 (resolution 4 cm−1). The background data were subtracted from the sample spectra.
3. Results
The aim of the FT–IR measurements was to provide information regarding the ratio of protium and deuterium atoms present in samples used for neutron crystallographic experiments. This method probes the solvent and labile hydrogen-atom content of the sample and is not affected by the non-exchangeable protium/deuterium atoms of the protein itself. Hence, as shown in Fig. 2, both deuterated and protiated protein show essentially identical spectra (Figs. 2a and 2c) when placed in the same protiated solvent, with a dominant peak at 3265 cm−1. Similarly, the spectra corresponding to protiated protein and deuterated protein (Figs. 2b and 2d) in deuterated buffer show no significant differences, with a peak at 2468 cm−1.
This method can therefore be applied to analyse solvent exchange at various stages from purification through to crystallization. The solvent environment in the crystallization well is assumed to be in equilibrium with the solvent environment of the crystal. Hence, by analysing the solvent composition of the well using FT–IR it is possible to infer the solvent composition of the crystal.
3.1. Back-exchange of solvent molecules
The Matthew's coefficient calculation (Vm = 2.09 Å3 Da−1) suggests that the solvent content of the crystals is ∼41.2% (both crystals A and B were produced from the same TTR variant and crystallized in the same and unit cell). Fig. 3 shows the FT–IR of the capillary solvent of a deuterated TTR crystal that has suffered severe back-exchange (crystal A) and that of a crystal of the same variant that has undergone only mild back-exchange (crystal B). The estimated percentages of H2O (absorbance at 3265 cm−1) and D2O (absorbance at 2468 cm−1) are shown in Table 1. About 40% of the solvent content in crystal A has been back-exchanged to H2O. This mode of exchange may occur for a number of reasons, including permeability of the sealing films used in crystallization wells or of the porous wax used as a capillary sealant, or following exposure to the environment during transfer of the crystal from the well to the capillary.
|
Figs. 4(a) and 4(c) show 2Fo–Fc neutron maps of the same region in crystals A and B, respectively (both to 1.8 Å resolution). Three ordered water molecules are known to be present in this part of the molecule. When both maps are contoured at 1.5σ, the neutron map of crystal B (Fig. 4c), where the percentage of H2O content is only 10% (Table 1), identifies the position and orientation of these three water molecules clearly. In contrast, cancellation effects in the corresponding neutron map for crystal A (Fig. 4a) have compromised the ability to model deuterium atoms effectively for the water molecules. The high level of H2O absorbance measured with FT–IR correlates with the lack of visibility for the deuterium atoms of these ordered water molecules in crystal A, confirming the global level of back-exchange. As shown in Figs. 4(b) and 4(d), the X-ray electron density maps for crystals A and B are identical, as D2O and H2O are not distinguishable by X-ray crystallography.
4. Discussion and conclusion
This paper demonstrates that FT–IR spectroscopy can be used in a routine way to assess back-exchange during sample preparation and also both before and after data collection. It is highly desirable to avoid back-exchange that could occur during data collection, since the final dataset may then contain a mixture of exchanged populations. It is perfectly feasible to conceive of an in situ FT–IR system on neutron diffractometers that would allow back-exchange to be monitored during data acquisition, and this could help to optimize the use of beamtime. Complementary spectroscopic arrangements of this type are widely used on X-ray crystallography beamlines (von Stetten et al., 2015).
While it is clear that solvent back-exchange occurs almost uniformly throughout the protein, that of the amide groups of the protein backbone is highly dependent on the region of the protein structure. It is perhaps not surprising that different regions of a biological macromolecule may exchange solvent deuterium/protium atoms at different rates, depending on accessibility and protein stability (Bennett et al., 2008). Analogous approaches have been pursued for H/D exchange studies using (Konermann et al., 2011; Wales & Engen, 2006) and have provided powerful insights to protein flexibility (Mehmood et al., 2012; Giladi et al., 2016). It is possible that neutron crystallography could exploit this type of methodology in the future.
Acknowledgements
AWY is supported by an ILL PhD studentship and Keele University. The authors acknowledge the use of the FT–IR facility at the Partnership for Soft Condensed Matter (PSCM) at ILL/ESRF, and David Hess for his help with the measurements. VTF acknowledges support from the EPSRC which funded the creation of the Deuteration Laboratory (D-Lab) in the Life Sciences Group at the ILL. The authors also thank the ILL for the provision of beamtime on the LADI-III diffractometer. Matthew Bowler (EMBL) and Daniele de Sanctis (ESRF) are thanked for help with X-ray data collection on the MASSIF-1 and ID30B beamlines, respectively.
Funding information
Funding for this research was provided by: Engineering and Physical Sciences Research Councilhttps://dx.doi.org/10.13039/501100000266 (award Nos. GR/R99393/01, EP/C015452/1).
References
Bennett, B. C., Gardberg, A. S., Blair, M. D. & Dealwis, C. G. (2008). Acta Cryst. D64, 764–783. Web of Science CrossRef CAS IUCr Journals Google Scholar
Blakeley, M. P., Hasnain, S. S. & Antonyuk, S. V. (2015). IUCrJ, 2, 464–474. Web of Science CrossRef CAS PubMed IUCr Journals Google Scholar
Blakeley, M. P., Ruiz, F., Cachau, R., Hazemann, I., Meilleur, F., Mitschler, A., Ginell, S., Afonine, P., Ventura, O. N., Cousido-Siah, A., Haertlein, M., Joachimiak, A., Myles, D. & Podjarny, A. (2008). Proc. Natl Acad. Sci. USA, 105, 1844–1848. Web of Science CrossRef PubMed CAS Google Scholar
Blakeley, M. P., Teixeira, S. C. M., Petit-Haertlein, I., Hazemann, I., Mitschler, A., Haertlein, M., Howard, E. & Podjarny, A. D. (2010). Acta Cryst. D66, 1198–1205. Web of Science CrossRef CAS IUCr Journals Google Scholar
Bouquiere, J. P., Finney, J. L., Lehmann, M. S., Lindley, P. F. & Savage, H. F. J. (1993). Acta Cryst. B49, 79–89. CSD CrossRef CAS Web of Science IUCr Journals Google Scholar
Bouquiere, J. P., Finney, J. L. & Savage, H. F. J. (1994). Acta Cryst. B50, 566–578. CrossRef CAS Web of Science IUCr Journals Google Scholar
Bowler, M. W. et al. (2015). J. Synchrotron Rad. 22, 1540–1547. Web of Science CrossRef IUCr Journals Google Scholar
Casadei, C. M., Gumiero, A., Metcalfe, C. L., Murphy, E. J., Basran, J., Concilio, M. G., Teixeira, S. C. M., Schrader, T. E., Fielding, A. J., Ostermann, A., Blakeley, M. P., Raven, E. L. & Moody, P. C. E. (2014). Science, 345, 193–197. Web of Science CrossRef CAS PubMed Google Scholar
Cuypers, M. G., Mason, S. A., Blakeley, M. P., Mitchell, E. P., Haertlein, M. & Forsyth, V. T. (2013). Angew. Chem. Int. Ed. 52, 1022–1025. Web of Science CrossRef CAS Google Scholar
Fisher, S. J., Blakeley, M. P., Howard, E. I., Petit-Haertlein, I., Haertlein, M., Mitschler, A., Cousido-Siah, A., Salvay, A. G., Popov, A., Muller-Dieckmann, C., Petrova, T. & Podjarny, A. (2014). Acta Cryst. D70, 3266–3272. Web of Science CrossRef IUCr Journals Google Scholar
Gardberg, A. S., Del Castillo, A. R., Weiss, K. L., Meilleur, F., Blakeley, M. P. & Myles, D. A. A. (2010). Acta Cryst. D66, 558–567. Web of Science CrossRef CAS IUCr Journals Google Scholar
Gerlits, O., Wymore, T., Das, A., Shen, C.-H., Parks, J. M., Smith, J. C., Weiss, K. L., Keen, D. A., Blakeley, M. P., Louis, J. M., Langan, P., Weber, I. T. & Kovalevsky, A. (2016). Angew. Chem. Int. Ed. 55, 4924–4927. Web of Science CrossRef CAS Google Scholar
Giladi, M., Almagor, L., van Dijk, L., Hiller, R., Man, P., Forest, E. & Khananshvili, D. (2016). Sci. Rep. 6, 20753. CrossRef PubMed Google Scholar
Haertlein, M., Moulin, M., Devos, J. M., Laux, V., Dunne, O. & Forsyth, V. T. (2016). Methods Enzymol. 566, 113–157. CrossRef PubMed Google Scholar
Haupt, M., Blakeley, M. P., Fisher, S. J., Mason, S. A., Cooper, J. B., Mitchell, E. P. & Forsyth, V. T. (2014). IUCrJ, 1, 429–438. Web of Science CrossRef CAS PubMed IUCr Journals Google Scholar
Haupt, M., Blakeley, M. P., Teixeira, S. C. M., Mason, S. A., Mitchell, E. P., Cooper, J. B. & Forsyth, V. T. (2011). Acta Cryst. F67, 1428–1431. Web of Science CrossRef IUCr Journals Google Scholar
Howard, E. I., Blakeley, M. P., Haertlein, M., Petit-Haertlein, I., Mitschler, A., Fisher, S. J., Cousido-Siah, A., Salvay, A. G., Popov, A., Muller-Dieckmann, C., Petrova, T. & Podjarny, A. (2011). J. Mol. Recognit. 24, 724–732. Web of Science CrossRef CAS PubMed Google Scholar
Howard, E. I., Guillot, B., Blakeley, M. P., Haertlein, M., Moulin, M., Mitschler, A., Cousido-Siah, A., Fadel, F., Valsecchi, W. M., Tomizaki, T., Petrova, T., Claudot, J. & Podjarny, A. (2016). IUCrJ, 3, 115–126. Web of Science CrossRef CAS PubMed IUCr Journals Google Scholar
Konermann, L., Pan, J. & Liu, Y.-H. (2011). Chem. Soc. Rev. 40, 1224–1234. Web of Science CrossRef CAS PubMed Google Scholar
Kwon, H., Basran, J., Casadei, C. M., Fielding, A., Schrader, T., Ostermann, A., Devos, J., Aller, P., Blakeley, M., Moody, P. C. E. & Raven, E. L. (2016). Nat. Commun. 7, 13445. CrossRef PubMed Google Scholar
Laulumaa, S., Blakeley, M. P., Raasakka, A., Moulin, M., Härtlein, M. & Kursula, P. (2015). Acta Cryst. F71, 1391–1395. CrossRef IUCr Journals Google Scholar
Mehmood, S., Domene, C., Forest, E. & Jault, J.-M. (2012). Proc. Natl Acad. Sci. USA, 109, 10832–10836. CrossRef CAS PubMed Google Scholar
Mueller-Dieckmann, C., Bowler, M. W., Carpentier, P., Flot, D., McCarthy, A. A., Nanao, M. H., Nurizzo, D., Pernot, P., Popov, A., Round, A., Royant, A., de Sanctis, D., von Stetten, D. & Leonard, G. A. (2015). Eur. Phys. J. Plus, 130, 70. Google Scholar
Munshi, P., Chung, S.-L., Blakeley, M. P., Weiss, K. L., Myles, D. A. A. & Meilleur, F. (2012). Acta Cryst. D68, 35–41. Web of Science CrossRef CAS IUCr Journals Google Scholar
Oksanen, E., Blakeley, M. P., El-Hajji, M., Ryde, U. & Budayova-Spano, M. (2014). PLoS One, 9, e86651. Web of Science CrossRef PubMed Google Scholar
Scheiner, S. & Čuma, M. (1996). J. Am. Chem. Soc. 118, 1511–1521. CrossRef CAS Google Scholar
Stetten, D. von, Giraud, T., Carpentier, P., Sever, F., Terrien, M., Dobias, F., Juers, D. H., Flot, D., Mueller-Dieckmann, C., Leonard, G. A., de Sanctis, D. & Royant, A. (2015). Acta Cryst. D71, 15–26. Web of Science CrossRef IUCr Journals Google Scholar
Tomanicek, S. J., Wang, K. K., Weiss, K. L., Blakeley, M. P., Cooper, J., Chen, Y. & Coates, L. (2011). FEBS Lett. 585, 364–368. Web of Science CrossRef CAS PubMed Google Scholar
Wales, T. E. & Engen, J. R. (2006). Mass Spectrom. Rev. 25, 158–170. CrossRef PubMed CAS Google Scholar
Weber, I. T., Waltman, M. J., Mustyakimov, M., Blakeley, M. P., Keen, D. A., Ghosh, A. K., Langan, P. & Kovalevsky, A. Y. (2013). J. Med. Chem. 56, 5631–5635. Web of Science CrossRef CAS PubMed Google Scholar
Yee, A. W., Moulin, M., Breteau, N., Haertlein, M., Mitchell, E. P., Cooper, J. B., Boeri Erba, E. & Forsyth, V. T. (2016). Angew. Chem. Int. Ed. 55, 9292–9296. CrossRef CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.